<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38652364</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2299-5684</ISSN><JournalIssue CitedMedium="Internet"><Volume>76</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Pharmacological reports : PR</Title><ISOAbbreviation>Pharmacol Rep</ISOAbbreviation></Journal><ArticleTitle>Role of the RAAS in mediating the pathophysiology of COVID-19.</ArticleTitle><Pagination><StartPage>475</StartPage><EndPage>486</EndPage><MedlinePgn>475-486</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s43440-024-00596-3</ELocationID><Abstract><AbstractText>The renin-angiotensin-aldosterone system (RAAS) holds a position of paramount importance as enzymatic and endocrine homeostatic regulator concerning the water-electrolyte and acid-base balance. Nevertheless, its intricacy is influenced by the presence of various complementary angiotensins and their specific receptors, thereby modifying the primary RAAS actions. Angiotensin-converting enzyme 2 (ACE2) acts as a surface receptor for SARS-CoV-2, establishing an essential connection between RAAS and COVID-19 infection. Despite the recurring exploration of the RAAS impact on the trajectory of COVID-19 along with the successful resolution of many inquiries, its complete role in the genesis of delayed consequences encompassing long COVID and cardiovascular thrombotic outcomes during the post-COVID phase as well as post-vaccination, remains not fully comprehended. Particularly noteworthy is the involvement of the RAAS in the molecular mechanisms underpinning procoagulant processes throughout COVID-19. These processes significantly contribute to the pathogenesis of organ complications as well as determine clinical outcomes and are discussed in this manuscript.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jasiczek</LastName><ForeName>Jakub</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Regional Specialist Hospital in Wroc&#x142;aw, Kamie&#x144;skiego 73a, Wroc&#x142;aw, 51-124, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doroszko</LastName><ForeName>Adrian</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, 4th Military Hospital, Faculty of Medicine, Wroclaw University of Science and Technology, Weigla 5, Wroc&#x142;aw, 50-981, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trocha</LastName><ForeName>Tymoteusz</ForeName><Initials>T</Initials><Identifier Source="ORCID">0009-0008-2554-6460</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, Wroclaw Medical University, Borowska 213, Wroc&#x142;aw, 50-556, Poland. tymoteusz.trocha@student.umw.edu.pl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trocha</LastName><ForeName>Ma&#x142;gorzata</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Clinical Department of Diabetology and Internal Disease, Wroclaw Medical University, Borowska 213, Wroc&#x142;aw, 50-556, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Pharmacol Rep</MedlineTA><NlmUniqueID>101234999</NlmUniqueID><ISSNLinking>1734-1140</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="D000085962">Angiotensin-Converting Enzyme 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="C000705307">ACE2 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012084" MajorTopicYN="Y">Renin-Angiotensin System</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000085962" MajorTopicYN="Y">Angiotensin-Converting Enzyme 2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ADAM17</Keyword><Keyword MajorTopicYN="N">Angiotensin</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Coagulation</Keyword><Keyword MajorTopicYN="N">RAAS</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>The authors declare that there is no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>24</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>23</Day><Hour>16</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>23</Day><Hour>11</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38652364</ArticleId><ArticleId IdType="pmc">PMC11126499</ArticleId><ArticleId IdType="doi">10.1007/s43440-024-00596-3</ArticleId><ArticleId IdType="pii">10.1007/s43440-024-00596-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Crowley SD, Gurley SB, Oliverio MI, Pazmino AK, Griffiths R, Flannery PJ, et al. Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system. J Clin Invest. 2005;115(4):1092&#x2013;9. doi: 10.1172/JCI23378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI23378</ArticleId><ArticleId IdType="pmc">PMC1070417</ArticleId><ArticleId IdType="pubmed">15841186</ArticleId></ArticleIdList></Reference><Reference><Citation>Miura S. Angiotensin II receptor research. Curr Pharm Des. 2013;19(17):2979&#x2013;80. doi: 10.2174/1381612811319170001.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612811319170001</ArticleId><ArticleId IdType="pubmed">23176222</ArticleId></ArticleIdList></Reference><Reference><Citation>Te Riet L, van Esch JH, Roks AJ, van den Meiracker AH, Danser AH. Hypertension: renin-angiotensin-aldosterone system alterations. Circ Res. 2015;116(6):960&#x2013;75. doi: 10.1161/CIRCRESAHA.116.303587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.116.303587</ArticleId><ArticleId IdType="pubmed">25767283</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270&#x2013;73. doi: 10.1038/s41586-020-2012-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2012-7</ArticleId><ArticleId IdType="pmc">PMC7095418</ArticleId><ArticleId IdType="pubmed">32015507</ArticleId></ArticleIdList></Reference><Reference><Citation>Riordan JF. Angiotensin-I-converting enzyme and its relatives. Genome Biol. 2003;4(8):225. doi: 10.1186/gb-2003-4-8-225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2003-4-8-225</ArticleId><ArticleId IdType="pmc">PMC193637</ArticleId><ArticleId IdType="pubmed">12914653</ArticleId></ArticleIdList></Reference><Reference><Citation>Krassnigg F, Niederhauser H, Fink E, Frick J, Schill WB. Angiotensin converting enzyme in human seminal plasma is synthesized by the testis, epididymis and prostate. Int J Androl. 1989;12(1):22&#x2013;8. doi: 10.1111/j.1365-2605.1989.tb01282.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2605.1989.tb01282.x</ArticleId><ArticleId IdType="pubmed">2541085</ArticleId></ArticleIdList></Reference><Reference><Citation>Dzau VJ, Bernstein K, Celermajer D, Cohen J, Dahl&#xf6;f B, Deanfield J, et al. Pathophysiologic and therapeutic importance of tissue ACE: a consensus report. Cardiovasc Drugs Ther. 2002;16(2):149&#x2013;60. doi: 10.1023/A:1015709617405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1015709617405</ArticleId><ArticleId IdType="pubmed">12090908</ArticleId></ArticleIdList></Reference><Reference><Citation>Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, et al. A novel angiotensin&#x2013;converting enzyme&#x2013;related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1&#x2013;9. Circ Res. 2000;87(5):E1&#x2013;9. doi: 10.1161/01.RES.87.5.e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.87.5.e1</ArticleId><ArticleId IdType="pubmed">10969042</ArticleId></ArticleIdList></Reference><Reference><Citation>Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ. A human homolog of angiotensin&#x2013;converting enzyme. Cloning and functional expression as a captopril&#x2013;insensitive carboxypeptidase. J Biol Chem. 2000;275(43):33238&#x2013;43. doi: 10.1074/jbc.M002615200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M002615200</ArticleId><ArticleId IdType="pubmed">10924499</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner AJ, Hooper NM. The angiotensin&#x2013;converting enzyme gene family: genomics and pharmacology. Trends Pharmacol Sci. 2002;23(4):177&#x2013;83. doi: 10.1016/S0165-6147(00)01994-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0165-6147(00)01994-5</ArticleId><ArticleId IdType="pubmed">11931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Vickers C, Hales P, Kaushik V, Dick L, Gavin J, Tang J, et al. Hydrolysis of biological peptides by human angiotensin&#x2013;converting enzyme&#x2013;related carboxypeptidase. J Biol Chem. 2002;277(17):14838&#x2013;43. doi: 10.1074/jbc.M200581200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M200581200</ArticleId><ArticleId IdType="pubmed">11815627</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrell LM, Risvanis J, Kubota E, Dean RG, MacDonald PS, Lu S, et al. Myocardial infarction increases ACE2 expression in rat and humans. Eur Heart J. 2005;26(4):369&#x2013;75. doi: 10.1093/eurheartj/ehi114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehi114</ArticleId><ArticleId IdType="pubmed">15671045</ArticleId></ArticleIdList></Reference><Reference><Citation>Garabelli PJ, Modrall JG, Penninger JM, Ferrario CM, Chappell MC. Distinct roles for angiotensin&#x2013;converting enzyme 2 and carboxypeptidase A in the processing of angiotensins within the murine heart. Exp Physiol. 2008;93(5):613&#x2013;21. doi: 10.1113/expphysiol.2007.040246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/expphysiol.2007.040246</ArticleId><ArticleId IdType="pmc">PMC2675708</ArticleId><ArticleId IdType="pubmed">18356559</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Patel VB, Parajuli N, Fan D, Basu R, Wang Z, et al. Heterozygote loss of ACE2 is sufficient to increase the susceptibility to heart disease. J Mol Med (Berl) 2014;92(8):847&#x2013;58. doi: 10.1007/s00109-014-1149-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00109-014-1149-y</ArticleId><ArticleId IdType="pubmed">24728465</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou X, Chen K, Zou J, Han P, Hao J, Han Z. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med. 2020;14(2):185&#x2013;92. doi: 10.1007/s11684-020-0754-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11684-020-0754-0</ArticleId><ArticleId IdType="pmc">PMC7088738</ArticleId><ArticleId IdType="pubmed">32170560</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi Qi F, Qian S, Zhang S, Zhang Z. Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochem Biophys Res Commun. 2020;526(1):135&#x2013;40. doi: 10.1016/j.bbrc.2020.03.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2020.03.044</ArticleId><ArticleId IdType="pmc">PMC7156119</ArticleId><ArticleId IdType="pubmed">32199615</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan C, Lu W, Li K, Ding Y, Wang J. ACE2 expression in kidney and testis may cause kidney and testis infection in COVID&#x2013;19 patients. Front Med (Lausanne) 2021;7:563893. doi: 10.3389/fmed.2020.563893.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.563893</ArticleId><ArticleId IdType="pmc">PMC7838217</ArticleId><ArticleId IdType="pubmed">33521006</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol. 2020;92(4):418&#x2013;23. doi: 10.1002/jmv.25681.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25681</ArticleId><ArticleId IdType="pmc">PMC7167049</ArticleId><ArticleId IdType="pubmed">31967327</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei J, Kusov Y, Hilgenfeld R. Nsp3 of coronaviruses: structures and functions of a large multi&#x2013;domain protein. Antiviral Res. 2018;149:58&#x2013;74. doi: 10.1016/j.antiviral.2017.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2017.11.001</ArticleId><ArticleId IdType="pmc">PMC7113668</ArticleId><ArticleId IdType="pubmed">29128390</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F. Structure, function, and evolution of coronavirus spike proteins. Annu Rev Virol. 2016;3(1):237&#x2013;61. doi: 10.1146/annurev-virology-110615-042301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-virology-110615-042301</ArticleId><ArticleId IdType="pmc">PMC5457962</ArticleId><ArticleId IdType="pubmed">27578435</ArticleId></ArticleIdList></Reference><Reference><Citation>Angeletti S, Benvenuto D, Bianchi M, Giovanetti M, Pascarella S, Ciccozzi M. COVID&#x2013;2019: the role of the nsp2 and nsp3 in its pathogenesis. J Med Virol. 2020;92(6):584&#x2013;8. doi: 10.1002/jmv.25719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25719</ArticleId><ArticleId IdType="pmc">PMC7228367</ArticleId><ArticleId IdType="pubmed">32083328</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Yi Y, Luo X, Xiong N, Liu Y, Li S, et al. Development and clinical application of a rapid IgM&#x2013;IgG combined antibody test for SARS&#x2013;CoV&#x2013;2 infection diagnosis. J Med Virol. 2020;92(9):1518&#x2013;24. doi: 10.1002/jmv.25727.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25727</ArticleId><ArticleId IdType="pmc">PMC7228300</ArticleId><ArticleId IdType="pubmed">32104917</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17(3):181&#x2013;92. doi: 10.1038/s41579-018-0118-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-018-0118-9</ArticleId><ArticleId IdType="pmc">PMC7097006</ArticleId><ArticleId IdType="pubmed">30531947</ArticleId></ArticleIdList></Reference><Reference><Citation>Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS&#x2013;CoV&#x2013;2 spike glycoprotein. Cell. 2020;181(2):281&#x2013;e926. doi: 10.1016/j.cell.2020.02.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.058</ArticleId><ArticleId IdType="pmc">PMC7102599</ArticleId><ArticleId IdType="pubmed">32155444</ArticleId></ArticleIdList></Reference><Reference><Citation>Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, et al. Cryo&#x2013;EM structure of the 2019&#x2013;nCoV spike in the prefusion conformation. Science. 2020;367(6483):1260&#x2013;3. doi: 10.1126/science.abb2507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb2507</ArticleId><ArticleId IdType="pmc">PMC7164637</ArticleId><ArticleId IdType="pubmed">32075877</ArticleId></ArticleIdList></Reference><Reference><Citation>Zipeto D, Palmeira JDF, Arga&#xf1;araz GA, Arga&#xf1;araz ER. ACE2/ADAM17/TMPRSS2 interplay may be the main risk factor for COVID&#x2013;19. Front Immunol. 2020;11:576745. doi: 10.3389/fimmu.2020.576745.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.576745</ArticleId><ArticleId IdType="pmc">PMC7575774</ArticleId><ArticleId IdType="pubmed">33117379</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagyas M, Fejes Z, S&#xfc;t&#x151; R, Nagy Z, Sz&#xe9;kely B, P&#xf3;csi M, et al. Circulating ACE2 activity predicts mortality and disease severity in hospitalized COVID&#x2013;19 patients. Int J Infect Dis. 2022;115:8&#x2013;16. doi: 10.1016/j.ijid.2021.11.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.11.028</ArticleId><ArticleId IdType="pmc">PMC8613979</ArticleId><ArticleId IdType="pubmed">34838959</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai Y, Kuba K, Penninger JM. The discovery of angiotensin&#x2013;converting enzyme 2 and its role in acute lung injury in mice. Exp Physiol. 2008;93:543&#x2013;8. doi: 10.1113/expphysiol.2007.040048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/expphysiol.2007.040048</ArticleId><ArticleId IdType="pmc">PMC7197898</ArticleId><ArticleId IdType="pubmed">18448662</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye R, Liu Z. ACE2 exhibits protective effects against LPS&#x2013;induced acute lung injury in mice by inhibiting the LPS&#x2013;TLR4 pathway. Exp Mol Pathol. 2020;113:104350. doi: 10.1016/j.yexmp.2019.104350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexmp.2019.104350</ArticleId><ArticleId IdType="pubmed">31805278</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, et al. Angiotensin&#x2013;converting enzyme 2 protects from severe acute lung failure. Nature. 2005;436(7047):112&#x2013;6. doi: 10.1038/nature03712.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature03712</ArticleId><ArticleId IdType="pmc">PMC7094998</ArticleId><ArticleId IdType="pubmed">16001071</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Murugesan P, Huang K, Cai H. NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets. Nat Rev Cardiol. 2020;17:170&#x2013;94. doi: 10.1038/s41569-019-0260-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-019-0260-8</ArticleId><ArticleId IdType="pmc">PMC7880919</ArticleId><ArticleId IdType="pubmed">31591535</ArticleId></ArticleIdList></Reference><Reference><Citation>Roche JA, Roche R. A hypothesized role for dysregulated bradykinin signaling in COVID&#x2013;19 respiratory complications. Faseb J. 2020;34(6):7265&#x2013;9. doi: 10.1096/fj.202000967.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202000967</ArticleId><ArticleId IdType="pmc">PMC7267506</ArticleId><ArticleId IdType="pubmed">32359101</ArticleId></ArticleIdList></Reference><Reference><Citation>Sodhi CP, Wohlford&#x2013;Lenane C, Yamaguchi Y, Prindle T, Fulton WB, Wang S, et al. Attenuation of pulmonary ACE2 activity impairs inactivation of des&#x2013;Arg9 bradykinin/BKB1R axis and facilitates LPS&#x2013;induced neutrophil infiltration. Am J Physiol Lung Cell Mol Physiol. 2018;314(1):L17&#x2013;31. doi: 10.1152/ajplung.00498.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00498.2016</ArticleId><ArticleId IdType="pmc">PMC5866432</ArticleId><ArticleId IdType="pubmed">28935640</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeung ML, Teng JLL, Jia L, Zhang C, Huang C, Cai JP, et al. Soluble ACE2&#x2013;mediated cell entry of SARS&#x2013;CoV&#x2013;2 via interaction with proteins related to the renin&#x2013;angiotensin system. Cell. 2021;184(8):2212&#x2013;e2812. doi: 10.1016/j.cell.2021.02.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.02.053</ArticleId><ArticleId IdType="pmc">PMC7923941</ArticleId><ArticleId IdType="pubmed">33713620</ArticleId></ArticleIdList></Reference><Reference><Citation>Karthika T, Joseph J, Das VRA, Nair N, Charulekha P, Roji MD, et al. SARS&#x2013;CoV&#x2013;2 cellular entry is independent of the ACE2 cytoplasmic domain signaling. Cells. 2021;10(7):1814. doi: 10.3390/cells10071814.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10071814</ArticleId><ArticleId IdType="pmc">PMC8304749</ArticleId><ArticleId IdType="pubmed">34359983</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman MM, Hasan M, Ahmed A. Potential detrimental role of soluble ACE2 in severe COVID&#x2013;19 comorbid patients. Rev Med Virol. 2021;31(5):1&#x2013;12. doi: 10.1002/rmv.2213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2213</ArticleId><ArticleId IdType="pmc">PMC8014495</ArticleId><ArticleId IdType="pubmed">33426683</ArticleId></ArticleIdList></Reference><Reference><Citation>Nejat R, Torshizi MF, Najafi DJ. S protein, ACE2 and host cell proteases in SARS&#x2013;CoV&#x2013;2 cell entry and infectivity; is soluble ACE2 a two blade sword? A narrative review. Vaccines (Basel) 2023;11(2):204. doi: 10.3390/vaccines11020204.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11020204</ArticleId><ArticleId IdType="pmc">PMC9968219</ArticleId><ArticleId IdType="pubmed">36851081</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwanaga N, Cooper L, Rong L, Maness NJ, Beddingfield B, Qin Z, et al. ACE2&#x2013;IgG1 fusions with improved in vitro and in vivo activity against SARS&#x2013;CoV&#x2013;2. iScience. 2022;25(1):103670. doi: 10.1016/j.isci.2021.103670.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.103670</ArticleId><ArticleId IdType="pmc">PMC8686446</ArticleId><ArticleId IdType="pubmed">34957381</ArticleId></ArticleIdList></Reference><Reference><Citation>Koka V, Huang XR, Chung AC, Wang W, Truong LD, Lan HY. Angiotensin II up&#x2013;regulates angiotensin I&#x2013;converting enzyme (ACE), but down&#x2013;regulates ACE2 via the AT1&#x2013;ERK/p38 MAP kinase pathway. Am J Pathol. 2008;172(5):1174&#x2013;83. doi: 10.2353/ajpath.2008.070762.</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2008.070762</ArticleId><ArticleId IdType="pmc">PMC2329828</ArticleId><ArticleId IdType="pubmed">18403595</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallagher PE, Ferrario CM, Tallant EA. MAP kinase/phosphatase pathway mediates the regulation of ACE2 by angiotensin peptides. Am J Physiol Cell Physiol. 2008;295(5):C1169&#x2013;74. doi: 10.1152/ajpcell.00145.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00145.2008</ArticleId><ArticleId IdType="pmc">PMC2585001</ArticleId><ArticleId IdType="pubmed">18768926</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel VB, Clarke N, Wang Z, Fan D, Parajuli N, Basu R, et al. Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM&#x2013;17: a positive feedback mechanism in the RAS. J Mol Cell Cardiol. 2014;66:167&#x2013;76. doi: 10.1016/j.yjmcc.2013.11.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2013.11.017</ArticleId><ArticleId IdType="pubmed">24332999</ArticleId></ArticleIdList></Reference><Reference><Citation>Palacios Y, Ruiz A, Ram&#xf3;n&#x2013;Luing LA, Oca&#xf1;a&#x2013;Guzman R, Barreto&#x2013;Rodriguez O, S&#xe1;nchez&#x2013;Monciv&#xe1;is A, et al. Severe COVID&#x2013;19 patients show an increase in soluble TNFR1 and ADAM17, with a relationship to mortality. Int J Mol Sci. 2021;22(16):8423. doi: 10.3390/ijms22168423.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22168423</ArticleId><ArticleId IdType="pmc">PMC8395100</ArticleId><ArticleId IdType="pubmed">34445140</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti V, Corbi G, Polito MV, Ciccarelli M, Manzo V, Torsiello M, et al. Sirt1 activity in PBMCS as a biomarker of different heart failure phenotypes. Biomolecules. 2020;10(11):1590. doi: 10.3390/biom10111590.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom10111590</ArticleId><ArticleId IdType="pmc">PMC7700185</ArticleId><ArticleId IdType="pubmed">33238655</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoda M, Kimura T, Tohmonda T, Morioka H, Matsumoto M, Okada Y, et al. Systemic overexpression of TNF&#x3b1;&#x2013;converting enzyme does not lead to enhanced shedding activity in vivo. PLoS ONE. 2013;8(1):e54412. doi: 10.1371/journal.pone.0054412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0054412</ArticleId><ArticleId IdType="pmc">PMC3544834</ArticleId><ArticleId IdType="pubmed">23342154</ArticleId></ArticleIdList></Reference><Reference><Citation>Haga S, Nagata N, Okamura T, Yamamoto N, Sata T, Yamamoto N, et al. TACE antagonists blocking ACE2 shedding caused by the spike protein of SARS&#x2013;CoV are candidate antiviral compounds. Antiviral Res. 2010;85(3):551&#x2013;5. doi: 10.1016/j.antiviral.2009.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2009.12.001</ArticleId><ArticleId IdType="pmc">PMC7114272</ArticleId><ArticleId IdType="pubmed">19995578</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamai L. Upregulation of the renin&#x2013;angiotensin system pathways and SARS&#x2013;CoV&#x2013;2 infection: the rationale for the administration of zinc&#x2013;chelating agents in COVID&#x2013;19 patients. Cells. 2021;10(3):506. doi: 10.3390/cells10030506.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10030506</ArticleId><ArticleId IdType="pmc">PMC7997276</ArticleId><ArticleId IdType="pubmed">33673459</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamai L. The Yin and Yang of ACE/ACE2 pathways: the rationale for the use of renin&#x2013;angiotensin system inhibitors in COVID&#x2013;19 patients. Cells. 2020;9(7):1704. doi: 10.3390/cells9071704.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9071704</ArticleId><ArticleId IdType="pmc">PMC7408073</ArticleId><ArticleId IdType="pubmed">32708755</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan S, Wang R, Chan JFW, Zhang AJ, Cheng T, Chik KKH et al. 2020. Metallodrug ranitidine bismuth citrate suppresses SARS&#x2013;CoV&#x2013;2 replication and relieves virus&#x2013;associated pneumonia in Syrian hamsters. Nat Microbiol. 2020;5(11):1439&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">33028965</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorenzen I, Lokau J, Korpys Y, Oldefest M, Flynn CM, K&#xfc;nzel U, et al. Control of ADAM17 activity by regulation of its cellular localisation. Sci Rep. 2016;6:35067. doi: 10.1038/srep35067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep35067</ArticleId><ArticleId IdType="pmc">PMC5059621</ArticleId><ArticleId IdType="pubmed">27731361</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou YJ, Okuda K, Edwards CE, Martinez DR, Asakura T, Dinnon KH, et al. SARS&#x2013;CoV&#x2013;2 reverse genetics reveals a variable infection gradient in the respiratory tract. Cell. 2020;182(2):429&#x2013;e4614. doi: 10.1016/j.cell.2020.05.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.05.042</ArticleId><ArticleId IdType="pmc">PMC7250779</ArticleId><ArticleId IdType="pubmed">32526206</ArticleId></ArticleIdList></Reference><Reference><Citation>Kocyigit A, Sogut O, Durmus E, Kanimdan E, Guler EM, Kaplan O, et al. Circulating furin, IL&#x2013;6, and presepsin levels and disease severity in SARS&#x2013;CoV&#x2013;2&#x2013;infected patients. Sci Prog. 2021;104(2suppl):368504211026119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10305811</ArticleId><ArticleId IdType="pubmed">34187224</ArticleId></ArticleIdList></Reference><Reference><Citation>To KF, Tong JH, Chan PK, Au FW, Chim SS, Chan KC, et al. Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in&#x2013;situ hybridization study of fatal cases. J Pathol. 2004;202(2):157&#x2013;63. doi: 10.1002/path.1510.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1510</ArticleId><ArticleId IdType="pmc">PMC7167900</ArticleId><ArticleId IdType="pubmed">14743497</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine&#x2013;Weber H, Schroeder S, Kr&#xfc;ger N, Herrler T, Erichsen S, et al. SARS&#x2013;CoV&#x2013;2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271&#x2013;e808. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Samudrala PK, Kumar P, Choudhary K, Thakur N, Wadekar GS, Dayaramani R, et al. Virology, pathogenesis, diagnosis and in&#x2013;line treatment of COVID&#x2013;19. Eur J Pharmacol. 2020;883:173375. doi: 10.1016/j.ejphar.2020.173375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2020.173375</ArticleId><ArticleId IdType="pmc">PMC7366121</ArticleId><ArticleId IdType="pubmed">32682788</ArticleId></ArticleIdList></Reference><Reference><Citation>Emami A, Javanmardi F, Pirbonyeh N, Akbari A. Prevalence of underlying diseases in hospitalized patients with COVID&#x2013;19: a systematic review and meta&#x2013;analysis. Arch Acad Emerg Med. 2020;8:e35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7096724</ArticleId><ArticleId IdType="pubmed">32232218</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P, Zhu L, Cai J, Lei F, Qin JJ, Xie J, et al. Association of inpatient use of angiotensin&#x2013;converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID&#x2013;19. Circ Res. 2020;126(12):1671&#x2013;81. doi: 10.1161/CIRCRESAHA.120.317134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.317134</ArticleId><ArticleId IdType="pmc">PMC7265882</ArticleId><ArticleId IdType="pubmed">32302265</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreutz R, Algharably EAE, Azizi M, Dobrowolski P, Guzik T, Januszewicz A, et al. Hypertension, the renin&#x2013;angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID&#x2013;19. Cardiovasc Res. 2020;116(10):1688&#x2013;99. doi: 10.1093/cvr/cvaa097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa097</ArticleId><ArticleId IdType="pmc">PMC7184480</ArticleId><ArticleId IdType="pubmed">32293003</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruzzenenti G, Maloberti A, Giani V, Biolcati M, Leidi F, Monticelli M, et al. Covid-19 Niguarda Working Group. COVID and cardiovascular diseases: direct and indirect damages and future perspective. High Blood Press Cardiovasc Prev. 2021;28(5):439&#x2013;45. doi: 10.1007/s40292-021-00464-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40292-021-00464-8</ArticleId><ArticleId IdType="pmc">PMC8233573</ArticleId><ArticleId IdType="pubmed">34173942</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrignani, Maloberti A, Temporelli, Binaghi, Cesaro A, Ciccirillo, et al. Long COVID: nosographic aspects and clinical epidemiology. G Ital Cardiol (Rome) 2022;23(9):651&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">36039714</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohmwald K, Diethelm-Varela B, Rodr&#xed;guez-Guilarte L, Rivera T, Riedel CA, Gonz&#xe1;lez PA, et al. Pathophysiological, immunological, and inflammatory features of long COVID. Front Immunol. 2024;15:1341600. doi: 10.3389/fimmu.2024.1341600.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2024.1341600</ArticleId><ArticleId IdType="pmc">PMC10932978</ArticleId><ArticleId IdType="pubmed">38482000</ArticleId></ArticleIdList></Reference><Reference><Citation>de Vries AAF. Renin-angiotensin system inhibition in COVID&#x2010;19 patients. Neth Heart J. 2020;28(7&#x2013;8):396&#x2013;405. doi: 10.1007/s12471-020-01439-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12471-020-01439-5</ArticleId><ArticleId IdType="pmc">PMC7278773</ArticleId><ArticleId IdType="pubmed">32514935</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallagher PE, Ferrario CM, Tallant EA. Regulation of ACE2 in cardiac myocytes and fibroblasts. Am J Physiol Heart Circ Physiol. 2008;295(6):H2373&#x2013;9. doi: 10.1152/ajpheart.00426.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00426.2008</ArticleId><ArticleId IdType="pmc">PMC2614534</ArticleId><ArticleId IdType="pubmed">18849338</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishiyama Y, Gallagher PE, Averill DB, Tallant EA, Brosnihan KB, Ferrario CM. Upregulation of angiotensin&#x2013;converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors. Hypertension. 2004;43(5):970&#x2013;6. doi: 10.1161/01.HYP.0000124667.34652.1a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.HYP.0000124667.34652.1a</ArticleId><ArticleId IdType="pubmed">15007027</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosnihan KB, Tallant EA, et al. Effect of angiotensin&#x2013;converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin&#x2013;converting enzyme 2. Circulation. 2005;111:2605&#x2013;10. doi: 10.1161/CIRCULATIONAHA.104.510461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.104.510461</ArticleId><ArticleId IdType="pubmed">15897343</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Chen B, Li Y, Zhang L, Wang Y, Yang S, et al. The use of renin&#x2013;angiotensin&#x2013;aldosterone system (RAAS) inhibitors is associated with a lower risk of mortality in hypertensive COVID&#x2013;19 patients: a systematic review and meta&#x2013;analysis. J Med Virol. 2021;93(3):1370&#x2013;7. doi: 10.1002/jmv.26625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26625</ArticleId><ArticleId IdType="pubmed">33095513</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng YY, Ma YT, Zhang JY, Xie X. COVID&#x2013;19 and the cardiovascular system. Nat Rev Cardiol. 2020;17:259&#x2013;60. doi: 10.1038/s41569-020-0360-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-0360-5</ArticleId><ArticleId IdType="pmc">PMC7095524</ArticleId><ArticleId IdType="pubmed">32139904</ArticleId></ArticleIdList></Reference><Reference><Citation>Iaccarino G, Borghi C, Cicero AFG, Ferri C, Minuz P, Muiesan ML, et al. Renin&#x2013;angiotensin system inhibition in cardiovascular patients at the time of COVID19: much ado for nothing? A statement of activity from the directors of the board and the scientific directors of the Italian society of hypertension. High Blood Press Cardiovasc Prev. 2020;27:105&#x2013;8. doi: 10.1007/s40292-020-00380-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40292-020-00380-3</ArticleId><ArticleId IdType="pmc">PMC7138256</ArticleId><ArticleId IdType="pubmed">32266708</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus&#x2013;induced lung injury. Nat Med. 2005;11:875&#x2013;9. doi: 10.1038/nm1267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1267</ArticleId><ArticleId IdType="pmc">PMC7095783</ArticleId><ArticleId IdType="pubmed">16007097</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie X, Chen J, Wang X, Zhang F, Liu Y. Age&#x2013; and gender&#x2013;related difference of ACE2 expression in rat lung. Life Sci. 2006;78:2166&#x2013;71. doi: 10.1016/j.lfs.2005.09.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2005.09.038</ArticleId><ArticleId IdType="pmc">PMC7094566</ArticleId><ArticleId IdType="pubmed">16303146</ArticleId></ArticleIdList></Reference><Reference><Citation>Sup&#xe9; S, Kohse F, Gembardt F, Kuebler WM, Walther T. Therapeutic time window for angiotensin&#x2013;(1&#x2013;7) in acute lung injury. Br J Pharmacol. 2016;173:1618&#x2013;28. doi: 10.1111/bph.13462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.13462</ArticleId><ArticleId IdType="pmc">PMC4842919</ArticleId><ArticleId IdType="pubmed">26895462</ArticleId></ArticleIdList></Reference><Reference><Citation>Tikellis C, Thomas MC. Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease. Int J Pept. 2012;2012:256294. doi: 10.1155/2012/256294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/256294</ArticleId><ArticleId IdType="pmc">PMC3321295</ArticleId><ArticleId IdType="pubmed">22536270</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, et al. Clinical and biochemical indexes from 2019&#x2013;nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020;63:364&#x2013;74. doi: 10.1007/s11427-020-1643-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11427-020-1643-8</ArticleId><ArticleId IdType="pmc">PMC7088566</ArticleId><ArticleId IdType="pubmed">32048163</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy R, Asante I, Liu S, et al. Circulating angiotensin peptides levels in acute respiratory distress syndrome correlate with clinical outcomes: a pilot study. PLoS ONE. 2019;14:e0213096. doi: 10.1371/journal.pone.0213096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0213096</ArticleId><ArticleId IdType="pmc">PMC6405137</ArticleId><ArticleId IdType="pubmed">30845246</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi GP, Sanga V, Barton M. Potential harmful effects of discontinuing ace&#x2013;inhibitors and arbs in COVID&#x2013;19 patients. Elife. 2020;9:e57278. doi: 10.7554/eLife.57278.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.57278</ArticleId><ArticleId IdType="pmc">PMC7198232</ArticleId><ArticleId IdType="pubmed">32250244</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurwitz D. Angiotensin receptor blockers as tentative SARS&#x2013;CoV&#x2013;2 therapeutics. Drug Dev Res. 2020;81(5):537&#x2013;40. doi: 10.1002/ddr.21656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ddr.21656</ArticleId><ArticleId IdType="pmc">PMC7228359</ArticleId><ArticleId IdType="pubmed">32129518</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou Z, Yan Y, Shu Y, Gao R, Sun Y, Li X, et al. Angiotensin&#x2013;converting enzyme 2 protects from lethal avian influenza a H5N1 infections. Nat Commun. 2014;5:3594. doi: 10.1038/ncomms4594.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms4594</ArticleId><ArticleId IdType="pmc">PMC7091848</ArticleId><ArticleId IdType="pubmed">24800825</ArticleId></ArticleIdList></Reference><Reference><Citation>Iaccarino G, Grassi G, Borghi C, Ferri C, Salvetti M, Volpe M, et al. Age and multimorbidity predict death among COVID&#x2013;19 patients: results of the SARS&#x2013;RAS study of the Italian society of hypertension. Hypertension. 2020;76(2):366&#x2013;72. doi: 10.1161/HYPERTENSIONAHA.120.15324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.120.15324</ArticleId><ArticleId IdType="pubmed">32564693</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancia G, Rea F, Ludergnani M, Apolone G, Corrao G. Renin&#x2013;angiotensin&#x2013;aldosterone system blockers and the risk of COVID&#x2013;19. N Engl J Med. 2020;382(25):2431&#x2013;40. doi: 10.1056/NEJMoa2006923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2006923</ArticleId><ArticleId IdType="pmc">PMC7206933</ArticleId><ArticleId IdType="pubmed">32356627</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez&#x2013;Ruiz I. RAAS inhibitors do not increase the risk of COVID&#x2013;19. Nat Rev Cardiol. 2020;17(7):383. doi: 10.1038/s41569-020-0401-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-0401-0</ArticleId><ArticleId IdType="pmc">PMC7243952</ArticleId><ArticleId IdType="pubmed">32444693</ArticleId></ArticleIdList></Reference><Reference><Citation>de Abajo FJ, Rodr&#xed;guez&#x2013;Mart&#xed;n S, Lerma V, Mej&#xed;a&#x2013;Abril G, Aguilar M, Garc&#xed;a&#x2013;Luque A, et al. Use of renin&#x2013;angiotensin&#x2013;aldosterone system inhibitors and risk of COVID&#x2013;19 requiring admission to hospital: a case&#x2013;population study. Lancet. 2020;395(10238):1705&#x2013;14. doi: 10.1016/S0140-6736(20)31030-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31030-8</ArticleId><ArticleId IdType="pmc">PMC7255214</ArticleId><ArticleId IdType="pubmed">32416785</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W, Li M, Dong Y, Zhou H, Zhang Z, Tian C et al. Diabetes is a risk factor for the progression and prognosis of COVID&#x2013;19. Diabetes Metab Res Rev. 2020:e3319.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7228407</ArticleId><ArticleId IdType="pubmed">32233013</ArticleId></ArticleIdList></Reference><Reference><Citation>Roca&#x2013;Ho H, Riera M, Palau V, Pascual J, Soler MJ. Characterization of ACE and ACE2 expression within different organs of the NOD mouse. Int J Mol Sci. 2017;18:E563. doi: 10.3390/ijms18030563.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18030563</ArticleId><ArticleId IdType="pmc">PMC5372579</ArticleId><ArticleId IdType="pubmed">28273875</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernard I, Limonta D, Mahal LK, Hobman TC. Endothelium infection and dysregulation by SARS&#x2013;CoV&#x2013;2: evidence and caveats in COVID&#x2013;19. Viruses. 2021;13:29. doi: 10.3390/v13010029.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13010029</ArticleId><ArticleId IdType="pmc">PMC7823949</ArticleId><ArticleId IdType="pubmed">33375371</ArticleId></ArticleIdList></Reference><Reference><Citation>Frantzeskaki F, Armaganidis A, Orfanos SE. Immunothrombosis in acute respiratory distress syndrome: cross talks between inflammation and coagulation. Respiration. 2017;93:212&#x2013;25. doi: 10.1159/000453002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000453002</ArticleId><ArticleId IdType="pubmed">27997925</ArticleId></ArticleIdList></Reference><Reference><Citation>Pober JS, Sessa WC. Evolving functions of endothelial cells in inflammation. Nat Rev Immunol. 2007;7:803&#x2013;15. doi: 10.1038/nri2171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2171</ArticleId><ArticleId IdType="pubmed">17893694</ArticleId></ArticleIdList></Reference><Reference><Citation>Abassi Z, Skorecki K, Hamo&#x2013;Giladi DB, Kruzel&#x2013;Davila E, Heyman SN. Kinins and chymase: the forgotten components of the renin&#x2013;angiotensin system and their implications in COVID&#x2013;19 disease. Am J Physiol Lung Cell Mol Physiol. 2021;320(3):L422&#x2013;9. doi: 10.1152/ajplung.00548.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00548.2020</ArticleId><ArticleId IdType="pmc">PMC7938643</ArticleId><ArticleId IdType="pubmed">33404363</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S, Liu Y, Wang X, Yang L, Li H, Wang Y, et al. SARS&#x2013;CoV&#x2013;2 binds platelet ACE2 to enhance thrombosis in COVID&#x2013;19. J Hematol Oncol. 2020;13(1):120. doi: 10.1186/s13045-020-00954-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13045-020-00954-7</ArticleId><ArticleId IdType="pmc">PMC7471641</ArticleId><ArticleId IdType="pubmed">32887634</ArticleId></ArticleIdList></Reference><Reference><Citation>Senchenkova EY, Russell J, Almeida&#x2013;Paula LD, Harding JW, Granger DN. Angiotensin II&#x2013;mediated microvascular thrombosis. Hypertension. 2010;56(6):1089&#x2013;95. doi: 10.1161/HYPERTENSIONAHA.110.158220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.110.158220</ArticleId><ArticleId IdType="pmc">PMC3023299</ArticleId><ArticleId IdType="pubmed">20975035</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez&#x2013;Farr&#xe9; A, S&#xe1;nchez de Miguel L, Mont&#xf3;n M, Jim&#xe9;nez A, Lopez&#x2013;Bloya A, G&#xf3;mez J, et al. Angiotensin II AT(1) receptor antagonists and platelet activation. Nephrol Dial Transpl. 2001;16(Suppl 1):45&#x2013;9. doi: 10.1093/ndt/16.suppl_1.45.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/16.suppl_1.45</ArticleId><ArticleId IdType="pubmed">11369820</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoll D, Yokota R, Sanches Arag&#xe3;o D, Casarini DE. Both aldosterone and spironolactone can modulate the intracellular ACE/ANG II/AT1 and ACE2/ANG (1&#x2013;7)/MAS receptor axes in human mesangial cells. Physiol Rep. 2019;7:e14105. doi: 10.14814/phy2.14105.</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.14105</ArticleId><ArticleId IdType="pmc">PMC6548847</ArticleId><ArticleId IdType="pubmed">31165585</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown Nancy J, Gainer James V, Stein CM, Vaughan Douglas E. Bradykinin stimulates tissue plasminogen activator release in human vasculature. Hypertension. 1999;33:1431&#x2013;35. doi: 10.1161/01.HYP.33.6.1431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.HYP.33.6.1431</ArticleId><ArticleId IdType="pubmed">10373228</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright FL, Vogler TO, Moore EE, Moore HB, Wohlauer MV, Urban S, et al. Fibrinolysis shutdown correlation with thromboembolic events in severe COVID&#x2013;19 infection. J Am Coll Surg. 2020;231:193&#x2013;e031. doi: 10.1016/j.jamcollsurg.2020.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2020.05.007</ArticleId><ArticleId IdType="pmc">PMC7227511</ArticleId><ArticleId IdType="pubmed">32422349</ArticleId></ArticleIdList></Reference><Reference><Citation>Nougier C, Benoit R, Simon M, Desmurs&#x2013;Clavel H, Marcotte G, Argaud L, et al. Hypofibrinolytic state and high thrombin generation may play a major role in SARS&#x2013;CoV-2 associated thrombosis. J Thromb Haemost. 2020;18:2215&#x2013;19. doi: 10.1111/jth.15016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15016</ArticleId><ArticleId IdType="pmc">PMC7405476</ArticleId><ArticleId IdType="pubmed">32668058</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraga&#x2013;Silva RA, Pinheiro SV, Gon&#xe7;alves AC, Alenina N, Bader M, Santos RA. The antithrombotic effect of angiotensin&#x2013;(1&#x2013;7) involves mas&#x2013;mediated NO release from platelets. Mol Med. 2008;14(1&#x2013;2):28&#x2013;35. doi: 10.2119/2007-00073.Fraga-Silva.</Citation><ArticleIdList><ArticleId IdType="doi">10.2119/2007-00073.Fraga-Silva</ArticleId><ArticleId IdType="pmc">PMC2078558</ArticleId><ArticleId IdType="pubmed">18026570</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraga&#x2013;Silva RA, Sorg BS, Wankhede M, Dedeugd C, Jun JY, Baker MB, et al. ACE2 activation promotes antithrombotic activity. Mol Med. 2010;16(5&#x2013;6):210&#x2013;5. doi: 10.2119/molmed.2009.00160.</Citation><ArticleIdList><ArticleId IdType="doi">10.2119/molmed.2009.00160</ArticleId><ArticleId IdType="pmc">PMC2811560</ArticleId><ArticleId IdType="pubmed">20111697</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramkowski K, Mogielnicki A, Leszczynska A, Buczko W. Angiotensin&#x2013;(1&#x2013;9), the product of angiotensin I conversion in platelets, enhances arterial thrombosis in rats. J Physiol Pharmacol. 2010;61(3):317&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">20610862</ArticleId></ArticleIdList></Reference><Reference><Citation>Mogielnicki A, Kramkowski K, Hermanowicz JM, Leszczynska A, Przyborowski K, Buczko W. Angiotensin&#x2013;(1&#x2013;9) enhances stasis&#x2013;induced venous thrombosis in the rat because of the impairment of fibrinolysis. J Renin Angiotensin Aldosterone Syst. 2014;15(1):13&#x2013;21. doi: 10.1177/1470320313498631.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1470320313498631</ArticleId><ArticleId IdType="pubmed">23884911</ArticleId></ArticleIdList></Reference><Reference><Citation>Henry BM, Vikse J, Benoit S, Favaloro EJ, Lippi G. Hyperinflammation and derangement of renin&#x2013;angiotensin&#x2013;aldosterone system in COVID&#x2013;19: a novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis. Clin Chim Acta. 2020;507:167&#x2013;73. doi: 10.1016/j.cca.2020.04.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2020.04.027</ArticleId><ArticleId IdType="pmc">PMC7195008</ArticleId><ArticleId IdType="pubmed">32348783</ArticleId></ArticleIdList></Reference><Reference><Citation>Aid M, Busman&#x2013;Sahay K, Vidal SJ, Maliga Z, Bondoc S, Starke C, et al. Vascular disease and thrombosis in SARS&#x2013;CoV&#x2013;2&#x2013;infected rhesus macaques. Cell. 2020;183(5):1354&#x2013;e6613. doi: 10.1016/j.cell.2020.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.10.005</ArticleId><ArticleId IdType="pmc">PMC7546181</ArticleId><ArticleId IdType="pubmed">33065030</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi S, Wollenzien H, Leclerc E, Jarajapu YP. Hypoxic regulation of angiotensin&#x2013;converting enzyme 2 and Mas receptor in human CD34&#x2009;+&#x2009;cells. J Cell Physiol. 2019;234(11):20420&#x2013;31. doi: 10.1002/jcp.28643.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.28643</ArticleId><ArticleId IdType="pmc">PMC6660366</ArticleId><ArticleId IdType="pubmed">30989646</ArticleId></ArticleIdList></Reference><Reference><Citation>Munavalli GG, Knutsen&#x2013;Larson S, Lupo MP, Geronemus RG. Oral angiotensin&#x2013;converting enzyme inhibitors for treatment of delayed inflammatory reaction to dermal hyaluronic acid fillers following COVID&#x2013;19 vaccination&#x2013;a model for inhibition of angiotensin II&#x2013;induced cutaneous inflammation. JAAD Case Rep. 2021;10:63&#x2013;8. doi: 10.1016/j.jdcr.2021.02.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jdcr.2021.02.018</ArticleId><ArticleId IdType="pmc">PMC7923909</ArticleId><ArticleId IdType="pubmed">33681439</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>